OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis

BMC Pulmonary Medicine

Research Article

Erika Fernanda Lindarte¹  Diana Guerrero Patiño¹  Jefferson Antonio Buendía² 

[1]Research Group in Pharmacology and Toxicology “INFARTO”, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia

[2]Research Group in Pharmacology and Toxicology “INFARTO”, Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia

[3]Facultad de Medicina, Universidad de Antioquia, Carrera 51D #62-29, Medellín, Colombia

关键词: Health economics;    Public health;    Healthcare;    Colombia;    Corticosteroids;   

DOI  :  10.1186/s12890-022-02264-9

 received in 2022-03-21, accepted in 2022-11-24,  发布年份 2022

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

Fig. 7

Fig. 3

Fig. 1

12936_2022_4386_Article_IEq142.gif